Robert M. Mader
- Chemical Health and Safety top 1%
- Occupational Therapy top 0.5%
- Safe Handling of Antineoplastic Drugs 11
- Oncology top 2%
- Cancer Treatment and Pharmacology 38
- Colorectal Cancer Treatments and Studies 28
- HER2/EGFR in Cancer Research 22
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 13
- Pollution top 5%
-
- Chemotherapy-related skin toxicity 15
-
- Lung Cancer Treatments and Mutations 11
-
- Genetic factors in colorectal cancer 10
- Co-authors
- Guenther G. StegerBlanka RizovskiMaria FuerhackerGünther StegerRupert BartschUrsula PluschnigChristoph ZielinskiMichael Gnant
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Chemotherapy and Pharmacology (6 papers)British Journal of Cancer (5 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Robert M. Mader
171 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Chemical Health and Safety 49
- Occupational Therapy 219
- Oncology 1.4k
- Cancer Research 743
- Pollution 324
Countries citing papers authored by Robert M. Mader
This map shows the geographic impact of Robert M. Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Mader more than expected).
Fields of papers citing papers by Robert M. Mader
This network shows the impact of papers produced by Robert M. Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Mader. The network helps show where Robert M. Mader may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert M. Mader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 33 | |
| 9 | 2012 | 68 | |
| 10 | 2011 | 53 | |
| 11 | 2009 | 22 | |
| 12 | 2008 | 12 | |
| 13 | 2007 | 6 | |
| 14 | 2006 | 53 | |
| 15 | 2000 | 18 | |
| 16 | 2000 | 25 | |
| 17 | 1994 | 9 | |
| 18 | 1994 | 1 | |
| 19 | Complete remission of metastasisted clear cell sarcoma of tendons and aponeuroses | 1991 | 20 |
| 20 | [Controlled double-blind study on the effectiveness and tolerability of a combination therapy in chronic alcoholic liver diseases]. | 1978 | 1 |
About Robert M. Mader
Robert M. Mader is a scholar working on Chemical Health and Safety, Oncology, Occupational Therapy, Cancer Research and Dermatology, having authored 176 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (38 papers), Colorectal Cancer Treatments and Studies (28 papers), HER2/EGFR in Cancer Research (22 papers), Chemotherapy-related skin toxicity (15 papers), Cancer Genomics and Diagnostics (13 papers), Safe Handling of Antineoplastic Drugs (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Chemical Health and Safety (49 citations), Occupational Therapy (219 citations), Oncology (1.4k citations), Cancer Research (743 citations) and Pollution (324 citations). Robert M. Mader has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Guenther G. Steger, Blanka Rizovski, Maria Fuerhacker, Günther Steger, Rupert Bartsch, Ursula Pluschnig, Christoph Zielinski, Michael Gnant, Susanne N. Mahnik and Margaretha Rudas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Breast Cancer Research and Treatment and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.